Challenges in pulmonary fibrosis • 4: Smoking-induced diffuse interstitial lung diseases

Thorax

Volumn 62, Issue 10, 2007, Pages 904-910

  Wells, Athol U ^a   Nicholson, Andrew G ^a   Hansell, David M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

BRONCHIOLITIS; BRONCHITIS; CIGARETTE SMOKING; CLINICAL FEATURE; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; INTERSTITIAL LUNG DISEASE; LANGERHANS CELL; LUNG FIBROSIS; LUNG FUNCTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SMOKING CESSATION;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG DISEASES, INTERSTITIAL; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 35349002184     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2004.031021     Document Type: Review

References (63)

1. Colby TV. Bronchiolitis: pathologic considerations. Am J Clin Pathol 1998;109:101-9.
2. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974;291:755-88.
3. Myers JL, Veal CF Jr, Shin MS, et al. Respiratory bronchiolitis causing interstitial lung disease: a clinicopathological study of six cases. Am Rev Respir Dis 1987;135:880-4.
4. Guerry-Force ML, Muller NL, Wright JL, et al. A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia and small airways disease. Am Rev Respir Dis 1987;135:705-12.
5. Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis- associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989;64:1373-80.
6. Katzenstein AA, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-15.
7. Fraig M, Shreesha U, Savici D, et al. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 2002;26:647-53.
8. Cottin V, Streichenberger N, Gamondes JP, et al. Respiratory bronchiolitis in smokers with spontaneous pneumothorax. Eur Respir J 1998;12:702-4.
9. Remy-Jardin M, Remy J, Gosselin B, et al. Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. Radiology 1993;186:643-51.
10. Agius RM, Rutman A, Knight RK, et al. Human pulmonary alveolar macrophages with smokers' inclusions: their relation to the cessation of cigarette smoking. Br J Exp Pathol 1986;67:407-13.
11. Moon J, du Bois RM, Colby TV, et al. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999;54:1009-14.
12. Carrington CB, Gaensler EA, Coutu RE, et al. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978;298:801-9.
13. Corrin B, Price AB. Electron microscopic studies in desquamative interstitial pneumonia associated with asbestosis. Thorax 1972;27:324-31.
14. Abraham JL, Hertzberg MA. Inorganic particulates associated with desquamative interstitial pneumonia. Chest 1981;80:675-705.
15. Bone RC, Wolfe J, Sobonya RE, et al. Desquamative interstitial pneumonia following long term nitrofurantoin therapy. Am J Med 1976;60:697-701.
16. Amir G, Ron N. Pulmonary pathology in Gaucher's disease. Hum Pathol 1999;30:668-70.
17. Craig PJ, Wells AU, Doffman S, et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004;45:275-82.
18. Elkin SL, Nicholosn AG, du Bois RM. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Semin Resp Crit Care Med 2001;22:387-97.
19. King TE. Respiratory bronchiolitis-associated interstitial lung disease. Clin Chest Med 1993;14:693-8.
20. Hyeneman LE, Ward S, Lynch DA, et al. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process. Am J Roentgenol 1999;173:1617-22.
21. Wright JL, Lawson LM, Pare PD, et al. Morphology of peripheral airways in current smokers and ex-smokers. Am Rev Respir Dis 1983;127:474-7.
22. Liebow AA, Steer A, Billingsley JG. Desquamative interstitial pneumonia. Am J Med 1965;39:369-404.
23. Myers JL. Respiratory bronchiolitis with interstitial lung disease. Semin Respir Med 1992;12:134-9.
24. Park JS, Brown KK, Tuder RM, et al. Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr 2002;26:13-20.
25. Remy-Jardin M, Remy J, Boulenguez C, et al. Morphologic effects of cigarette smoking on airways and pulmonary parenchyma in healthy adult volunteers: CT evaluation and correlation with pulmonary function tests. Radiology 1993;186:107-15.
26. Muller NL, Miller RR. Diseases of the bronchioles: CT and histopathologic findings. Radiology 1995;196:3-12.
27. Holt RM, Schmidt RA, Godwin JD, et al. High-resolution CT in respiratory bronchiolitis-associated interstitial lung disease. J Comput Assist Tomogr 1993;17:46-50.
28. Essadki O, Chartrand-Lefebvre C, Briere J, et al. Respiratory bronchiolitis: radiographic and CT findings in a pathologically proven case. Eur Radiol 1998;8:1674-6.
29. Kurumagawa T, Kobayashi H, Kanoh S, et al. Respiratory bronchiolitis-associated interstitial lung disease (in Japanese). Nihon Kokyuki Gakkai Zasshi 1998;36:881-5.
30. Hartman TE, Tazelaar HD, Swensen SJ, et al. Cigarette smoking: CT and pathologic findings of associated pulmonary diseases. Radiographics 1997;17:377-90.
31. Verschakelen JA, Scheinbaum K, Bogaert J, et al. Expiratory CT in cigarette smokers: correlation between areas of decreased lung attenuation, pulmonary function tests and smoking history. Eur Radiol 1998;8:1391-9.
32. Mastora I, Remy-Jardin M, Sobaszek A, et al. Thin-section CT finding in 250 volunteers: assessment of the relationship of CT findings with smoking history and pulmonary function test results. Radiology 2001;218:695-702.
33. Hansell DM, Rubens MB, Padley SPG, et al. Obliterative bronchiolitis: individual CT signs of small airways disease and functional correlation. Radiology 1997;203:721-6.
34. Hansell DM, Wells AU, Padley SPG, et al. Hypersensitivity pneumonitis: correlation of individual CT patterns and functional abnormalities. Radiology 1996;199:123-8.
35. Hansell DM, Wells AU, Rubens MB, et al. Bronchiectasis: functional significance of areas of increased transradiancy on expiratory computed tomography. Radiology 1994;193:369-74.
36. Hansell DM, Milne DG, Wilsher ML, et al. Pulmonary sarcoidosis: morphologic associations of airflow obstruction on thin section computed tomography. Radiology 1998;209:697-704.
37. Hartman TE, Primack SL, Swensen SJ, et al. Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1993;187:787-90.
38. Flaherty KR, Travis WD, Colby TV, et al. Histologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001;164:1722-7.
39. Wells AU, King AD, Rubens MB, et al. Lone CFA: a functional-morphological correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med 1997;155:1367-75.
40. Nicholson AG, Colby TV, du Bois RM, et al. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000;162:2213-7.
41. Prigent A, Lamblin C, Copin MC, et al. Respiratory bronchiolitis with diffuse interstitial lung disease (in French). Rev Mal Respir 2001;18:201-4.
42. Veeraraghavan S, Latsi PI, Wells AU, et al. Bronchoalveolar lavage findings in idiopathic non-specific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J 2006;22:239-44.
43. Drent M, van Nierop MA, Gerritsen FA, et al. A computed program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 1996;153:736-41.
44. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000;161:646-64.
45. American Thoracic Society/European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
46. Aubry MC, Wright JL, Myers JL. The pathology of smoking-related lung diseases. Clin Chest Med 2000;21:11-35.
47. Remy-Jardin M, Edme J-L, Boulenguez C, et al. Longitudinal follow-up study of smoker's lung with thin-section CT in correlation with pulmonary function tests. Radiology 2002;222:261-70.
48. Shintani H, Fujimura M, Yasui M, et al. Acute eosinophilic pneumonia caused by cigarette smoking. Intern Med 2000;39:66-8.
49. Nakajima M, Manabe T, Niki Y, et al. Cigarette smoke-induced acute eosinophilic pneumonia. Radiology 1998;207:829-31.
50. Watanabe K, Fujimura M, Kasahara K, et al. Acute eosinophilic pneumonia following cigarette smoking: a report including cigarette-smoking challenge test. Intern Med 2002;41:1016-20.
51. Miki K, Miki M, Nakamura Y, et al. Early-phase neutrophilia in cigarette smoke-induced acute eosinophilic pneumonia. Intern Med 2003;42:839-45.
52. Selman M. Hypersensitivity pneumonitis. In: Schwarz MI, King TE, eds. Interstitial lung disease. Hamilton, Ontario: Decker, 2003:452-84.
53. Douglas JG, Middleton WG, Gaddie J, et al. Sarcoidosis: a disorder commoner in non-smokers? Thorax 1986;41:787-91.
54. Johansson S, Bjermer L, Franzen L, et al. Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. Radiother Oncol 1998;49:41-7.
55. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980;35:171-80.
56. Watters LC, Schwarz MI, Cherniack RM, et al. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987;135:696-704.
57. Schwartz DA, Helmers RA, Galvin JR, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994;149:450-4.
58. Carrington CB, Gaensler EA, Coutu RE, et al. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978;298:801-9.
59. Johnston IDA, Prescott RJ, Chalmers JC, for the Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society, et al. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax 1997;52:38-44.
60. Baumgartner KM, Samet J, Sidley CA, the Collaborating Centers, et al. Cogarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997;155:242-8.
61. King Jr TE, Tooze JA, Schwarz MI, et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171-81.
62. Selman M. The spectrum of smoking-related interstitial lung disorders: the never-ending story of smoke and disease. Chest 2003;124:1185-7.
63. Vassallo R, Jensen EA, Colby TV, et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis. Chest 2003;124:1199-205.